• EN
Search

ENP project 2016

 

ENP project activities in 2016

The EMCDDA project targets 7 European Neighbourhood Policy (ENP) partner countries. These are: Armenia, Azerbaijan, Georgia, Israel, Moldova, Morocco and Ukraine.

Timetable: January 2014–June 2016
Objective: The overall objective of the EMCDDA-ENPI project is to strengthen the capacity of ENP Partner countries to react to new challenges and developments of the drugs situation.

In order to achieve this, the project has defined a set of measurable and specific objectives:

  • to support the partner countries to produce new information on their drugs situation;
  • to develop the capacity for monitoring;
  • to strengthen the reporting and dissemination of information.

Expected results are:

  • a better knowledge of recent and emerging trends in drug use in the partner ENP countries among young people;
  • the Early Warning System covers the new ENP partner countries for its ALERT component, which makes it more comprehensive and more accurate and enables effective exchange of information between EU member states and ENP countries;
  • increased capacity for data collection, analysis and interpretation in the ENP countries, as a result of the knowledge transfer facilitated by the project;
  • decision-makers at national and EU level are better informed on the drugs situation and on the need for interventions;ENP partners and other Reitox members have a better knowledge and understanding of the drugs situation and of the role of drug monitoring.

Reitox national Academy for Ukraine on ‘Contemporary approaches for drug monitoring’, Kiev, 1–2 March

Ukrainian flag

This Reitox Academy was organised following a request from the Ukrainian Monitoring and Medical Center on Alcohol and Drugs. It was the first national activity with the newly-appointed monitoring centre and gathered up to 40 national experts, as well as representatives from the United Nations Office on Drugs and crime and UNICEF.

The participants discussed tools and methods used for collecting data on drug use prevalence, drug treatment, as well as harms and harm reduction in the European Union Member States and in Ukraine. Presentations by Ukrainian experts highlighted achievements in data collection on drug use among young people and in schools, as well as the significant investments made in developing monitoring systems for the collection of data on the prevalence of drug-related infectious diseases and harm reduction measures in the country. Monitoring new psychoactive substances and use of new methods for monitoring drugs, such as wastewater analysis, were of particular interest to the Ukrainian experts.

Setting up a national drug information system in Lebanon, Beirut, 3–4 March

conference room

The setting-up of the future national drug observatory is a joint project between the Lebanese Ministry of Public Health and the Pompidou Group. The EMCDDA also contributes to this project by attending technical meetings and sharing EU methodologies. In March, the first visit of EMCDDA staff to Lebanon was organised in order to meet the project’s core team, dedicated to the creation of the future national drug observatory. A technical meeting with this team from the Ministry of Public Health was an opportunity to share EU best practice and tools, in order to start mapping the drug information system in the country.

Reitox regional Academy for ENP beneficiaries on ‘Data collection and reporting on drug seizures’, Budapest, 17–18 March

A training Academy on data collection and reporting on drug seizures was organised in Budapest in partnership with the European Police College (CEPOL). The training course aimed at developing supply data collection processes, in line with EU standards, in Georgia, Moldova, and Ukraine, and also shared with the attendees the methodology and tools for collecting country level drug seizure data, as per the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) protocols and the monitoring of illicit drugs in Europe.

16th annual meeting of the Reitox Early Warning System network in conjunction with the 5th law enforcement expert meeting on new psychoactive substances, Lisbon, 19–20 May

conference room

The Early Warning System (EWS) works by collecting information on the appearance of new psychoactive substances (NPS) from the 28 Member States, Turkey and Norway and then monitoring them, thus allowing the EU to respond rapidly to emerging threats. The specific objectives of this annual meeting were to discuss the recent developments concerning NPS at national level, in particular those related to recent changes and concerns in national EWS and risk assessment systems and in-depth discussion of synthetic cannabinoids markets. Moreover, in 2016 the meeting was held in conjunction with the 5th law enforcement expert meeting on new psychoactive substances. A representative from Georgia, Israel and Ukraine, respectively, attended the meeting as observers.

Drug-related infectious diseases (DRID) experts meeting (6–8 June) and treatment demand indicator (TDI) experts meeting (8-9 June), Lisbon, 6-9 June

conference room

Experts from Armenia, Moldova, Georgia, Israel and Ukraine attended the annual key indicators meetings organised by the EMCDDA in Lisbon. These meetings help facilitate exchanges among experts on the latest developments in both related areas.

In 2016, the DRID meeting focused among other topics on the update of the regional assessment of the HIV risk, prevalence infections and responses to infectious diseases such as treatment to Hepatitis C.

The agenda of the TDI meeting included sharing the results of the implementation of the new TDI protocol and the EMCDDA treatment monitoring strategy. The participation of ENP experts in the meetings helped enhance the knowledge we have on the drugs situation outside the EU, by bringing some insight on the state of play in their respective countries.

Second meeting related to the national information system in Lebanon, 21–22 June

conference room

This year’s DRID key epidemiological indicator meeting focused on the most recent trends and briefings by national experts, such as updating the regional assessment of HIV risks and responses; hepatitis C infections and treatment; botulism and other infections; emerging risks related to the injection of stimulants, including new psychoactive substances; and drug-related health issues among prison populations. It included two sets of parallel workshops and four ‘conference-like’ plenaries.

The ENP1 project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ funded by the European Commission, financed the participation of a representative from Israel and Moldova, respectively, at this meeting.

National Reitox Academy for Armenia on ‘Monitoring and control of new psychoactive substances’, Yerevan, Armenia, 21–22 June

Armenian flag

This Reitox Academy was organised in cooperation with the National Security Council of the Republic of Armenia. During two days of the meeting, experts from Poland, Latvia, Slovenia and the EMCDDA discussed with participants how the EU Early Warning System operates and how new psychoactive substances (NPS) are monitored in Europe. The meeting was also an opportunity to exchange experiences on legal practices for the control of NPS and discuss public health responses to new psychoactive substances. The meeting was attended by more than 20 Armenian experts representing various law enforcement and security bodies, as well as the Ministry of Health, the Ministry of Education and some non-governmental organisations.

ENPI–EMCDDA Final Conference, Lisbon, 29 June

conference room

The EMCDDA hosted a conference marking the end of a two-year technical cooperation project within the framework of the European Neighbourhood Policy (ENP)(1). The conference is being held in association with the European Commission’s Directorates-General for Migration and Home Affairs (DG-HOME) and for Neighbourhood and Enlargement Negotiations (DG-NEAR).

The final conference took stock of the project objectives, findings, lessons learned and the way forward. Sessions covered: the collection, analysis and assessment of drug seizure data from selected countries near the EU; support for national drug monitoring capacity building; and the production of new information on the drug situation. The meeting also included a visit to a drug treatment centre and to the forensic laboratory of the Portuguese judicial police, organised in cooperation with the Portuguese Reitox focal point (SICAD.

(1) The 16 ENP countries are: Algeria, Armenia, Azerbaijan, Belarus, Egypt, Georgia, Israel, Jordan, Libya, Lebanon, Moldova, Morocco, Palestine, Syria, Tunisia and Ukraine http://eeas.europa.eu/enp/index_en.htm

Page last updated: Monday, 08 May 2017